Keywords: product, license, news, brief, bayer, says, signed

Product License News In Brief

Article | 20 November 1997

Print This

- Bayer says that it has signed an exclusive licensing agreement withSanofi to market the antidiabetic agent Miglitol (a synthetic alpha ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in